As the supply for the H1N1, or swine flu, vaccine trickles in slower than expected, officials in Marion and Polk counties are scrambling to keep up with demand     Marion County Health Department began offering appointments Thursday for residents without health insurance to get the H1N1 vaccine. In less than a day, those appointments were filled.

In Polk County, health officials ran out of vaccine after distributing 1,085 doses during a community clinic hosted at the Polk County Fairgrounds in Rickreall on Wednesday. About 250 people were turned away.

“Because we were one of the first (clinics), there was a very high demand, and it exceeded the number of doses,” public health manager Andy Walker said.

Public health departments are distributing the H1N1 vaccine to people in targeted priority groups: pregnant women, anyone in a household and caregivers for infants younger than six months; young children and adults from six months to 24 years old; and adults 25 to 64 who have health conditions associated with a higher risk of medical complications from the flu.

County health departments were directed to have 30 percent of allotted vaccine available to anyone in the priority groups without insurance or a medical provider; the other 70 percent is being distributed among school districts, health care providers and other agencies such as front-line emergency responders.

In Polk County, Walker said schools are reporting students out sick, but he’s keeping a closer eye on the severity of cases. So far, Polk County has had five cases that required hospitalization since September. Marion County has had 22 hospitalizations.

“It’s there, it’s present in the community,” Walker said. “People are getting the flu, but not everybody is getting sick from the flu — it’s not spreading aggressively.”

Marion County is distributing its vaccine on an appointment-only basis in order to streamline wait times and ensure priority groups are served first.

Anyone in a priority group without a medical provider or insurance can call Marion County Health Department to schedule an appointment. All other adults should contact their medical provider hursday was the first day the county opened its appointment line, and by mid-day the appointment slots were filled. Anyone wanting to make an appointment can call the health department beginning MondayMarion County health officials are not releasing specific number of doses available by appointment because of the constantly changing allotment.

“At this time, the vaccine shipments are unpredictable,” Marion County Public Health Officer Dr. Karen Landers said. “Scheduling appointments based on the number of vaccine we have is the best way to ensure that the people who have an appointment will get vaccinated. Eventually there will be enough vaccine for everyone who wants it; however, it will take some time.”

Spokeswoman Tonya Johnson said officials expect enough vaccine eventually will arrive, but shipments were taking longer than anticipated.

“We want people to know that we’re doing everything we can to get the vaccine out,” Johnson said. “We appreciate their patience. It’s basically out of our control.”

Once people in the priority groups have had access to the vaccine, the Marion County Health Department will make the H1N1 vaccine available to the general public through local health clinics, pharmacies and at the health department.

Marion County officials still are working with Salem-Keizer School District to plan vaccination clinics.

Ruth Gelbrich, the director of student services, said because of the delay in vaccines, no clinics would be held within the schools until at least the week of Nov. 16.

Gelbrich said Salem-Keizer officials were close to preparing its first flu clinic at a high school and have it serve the area feeder schools, but cancelled that event because a lack of vaccine supply.

District officials will have daily attendance counts by next week to monitor absentee rates among students and staff — until now, attendance data from all schools was not collected on a daily basis, Gelbrich said.

“We’re hearing that the numbers are rising,” she said.

So far, no Salem-Keizer schools have considered closing, but absentee numbers are higher to date than a year ago, she said. Individual schools make the decision to close depending on a shortage of students or staff.

Flu toolkits filled with face masks, digital thermometers, sanitizing wipes and hand sanitizer were distributed among many schools, and more were being prepared, Gelbrich said

The publicity for the H1N1 swine flu vaccination is hitting all areas with force.  The newsmedia, the press, the medical profession and even your job might be impacted.  My business has requested that all employees report whether they get the H1N1 vaccination.  Is this pressure to get the shot or vaccine?  Be sure and read all the facts and make a responsible decision on your own.

I have written several articles about the pros and cons to the H1N1 vaccine.  It is not my decision whether you take the shot or get vaccinated, it is yours.  My concern is that you read all about the vaccine and decide if it is right for you.  

Here are three concerns you must keep in mind!

1. Has the vaccine been sufficiently tested and evaluate?  We could debate this one for hours but you need to seriously determine this on your own.  We are likely not in the field for testing vaccines so contact the CDC and NIH but also do some independent research as well.  Each manufacturer has different ways for testing the vaccine and we as consumers are at the mercy of the “system” to hope it is tested sufficiently and accurately.  A fear I have is how do we know if it has been tested?  As I read in one article, a major manufacturer of the H1N1 vaccine admitted to the Associated Press that their vaccine will be available to the public before trial testing had been completed.

2. What legal recourses do you have if you take the vaccine and get sick and even have severe complications?  At present, the legal recourses for you as an individual are limited.  If problems prevail on a large scale, there will likely be an ambulance chasing lawyer who will put together a class action suit.  But for the time being the law has been established in favor of the pharmaceutical companies not the consumer.  The 2001 the law granted those who develop and recommend vaccines during a “health emergency” immunity.  This is in essence a free pass for the pharmaceutical companies during if the H1N1 is declared a “health emergency.”

3. How has the vaccine been test on young children below the age of 4?  I’ve been researching this subject with great detail and cannot find any credible information.  I fear that not until a tragedy results where a young child is vaccinated and dies will we be presented with facts.  Deciding whether you let your young child get the vaccine may be a life or death situation.  So choose wisely.

Please don’t get caught up in all the hype by the media and news shows regarding the exceptional cases that make the news.  These are the rare cases and notice that there is never a follow-up to confirm or evaluate how the disease was contracted or if in fact how we know the victim had the H1N1.  We are all at the mercy of what is presented in the news sound bytes or presentations.  Remember that news thrives on sensationalism, not always sound, honest and factual reporting.  As an article marketer for you business internet money online opportunity, report the facts and let your audience and customers decide.

As the nights get cooler, and the trees begin to change color, there is no doubt that fall is on the way.  And with fall comes flu season.  This year, in particular, many are worried about the H1N1 virus, commonly referred to as “swine flu.”  Many are concerned about the reported shortage of H1N1 vaccine.

Because of the serious threat posed by this strain of flu, health authorities are on alert.  Unfortunately, however, the US health department reports that 120 million doses of swine flu vaccine will be required to protect the population.  Only one third of that number will be available in October when flu season begins!

What is the reason for this shortage?  Dr. Robin Robinson, of the US Dept of HHS (Health & Human Services) was quoted in Reuters (8/18/09) as stating:  “We’re trying to bring on more manufacturing…hopefully there are ways to bring that number up.”  

The Dept of HHS is attempting to add new manufacturing companies because the logjam seems to lie with current capacity.  

Since there is a shortage of H1N1 vaccine, the supply will not cover the entire population.  Accordingly,  the government is planing to ration the swine flu vaccine.  As flu season begins, the only people that will be able to be inoculated are pregnant women, people who work in  public health, and children that are under the age of four.

How serious is the problem?  Even though the H1N1 vaccination will be the largest in human history, the White House Council for Science has estimated that there could be 30,000 to 90,000 deaths resulting from the swine flu strain during this 2009 flu season.

Are public health officials concerned?   Naturally.  They are worried that people that do not receive vaccinations will become ill.  

The World Health Organization has declared a pandemic, because the H1N1 flu strain affects the entire globe, not just the United States.

Reportedly, dosages available in the United States should increase to about 80 million by early November (well into the flu season), according to health officials.  Even so, one third of the population will remain without vaccine.  

There is no question that there is a shortage of H1N1 vaccine.

As we go into this flu season, avoid public places like schools and large public buildings if you possibly can.   Do your best to stay away from people who are coughing or sneezing.  Practice ritual hand washing with soap and hot water.  When a sink is not available, use hand sanitizers.  And if you become ill, stay home!  Isolate yourself or your sick family members so that they will not infect others!

I chose to research information about the H1N1 virus to make a more educated decision on whether or not I should have my daughter vaccinated.
The presence of this virus was brought to our attention in the spring of 2009 when the Mexican government began closing most of the public facilities in Mexico City due to an outbreak. Evidently, there was already a case of widespread swine flu there before it caught our attention. It spread to the United States as well as many other countries by June of 2009. The swine flu dates back to 1918 when it was commonly referred to as the Spanish Flu, though its origin was never detected. Five hundred million people were affected world-wide and 50 to 100 million people died as result. The virus attacked people with healthy immune systems and the popular idea that children and elderly people would be affected the most was not the case. A healthy immune system would over-do itself to try to beat the virus and in the meantime, it would overreact and actually have the reverse effect on the body.
A strain of H1N1 was responsible for a smaller outbreak in 1976 where a soldier at Fort Dix died right after complaining of not feeling well. This strain was controlled, but a new one was born right after which spread very quickly. A vaccination was created to prevent the re-occurrence of the epidemic that took so many lives in 1918. The vaccination helped with the spread of the virus, but it ended up taking more lives than the virus itself. Many died as the result of adverse reactions to the vaccine and 532 people were diagnosed with Guillian-Barré syndrome as a direct result from taking it. This is an autoimmune disorder that results in nerve damage among many other debilitating health problems. Many people who have Guillian-Barré syndrome need to undergo a form of dialysis where antibodies are removed from the blood and the blood is replenished back to the body. It is possible to survive this health condition but there is usually a long road to recovery which can take many years.
There was a limited case of swine flu labeled as Zoonosis which was detected in 1988 when a pregnant woman in Wisconsin died after being in contact with infected pigs at a fair. There were a few others who came in contact with her that were infected with a mild form of the virus. Many pigs were found to be infected across the entire U.S. in 1998 and it was deemed that the pigs had a typical flu that transformed into a new strain due to a combination of their own flu fused with those of humans and birds. Many pigs were infected in the Philippines in 2007 as well. The H1N1 virus is a combination of influenza spun from four different forms including 2 parts human flu, 1 part bird flu and 1 part pig flu.
The 2009 H1N1 virus exhibits symptoms that are similar to your everyday flu. These include a sudden fever and cough along with any of the other common flu symptoms like chills and body aches. Most people who catch the virus can treat it as they normally would with bed rest and fluids. People who have a weakened immune system can experience further complications like pneumonia or even respiratory failure. Those who are considered to be at a higher risk are people under 5 and over 65 years old. People who have recently undergone asthma treatments by taking prescription drugs are also at risk. H1N1 can have an incubation period of up to 7 days, though this has not been confirmed. It can be acquired the same way as the common flu through something as simple as a sneeze. One out of 1,000 people died of the swine flu which is comparable to the amount of people who have died from common flu. The best way to prevent from getting sick is by routine hand washing and covering your mouth and nose with a tissue when you sneeze or cough and quickly disposing it.
How do we know if we have a common flu or the swine flu? In most cases we don’t and physicians normally do not test patients to differentiate which virus they have. They will conduct a test if the symptoms are severe by administering a blood test or swabbing the back of the nose and throat. H1N1 is usually treated with Tamiflu or Relenza when it is diagnosed. These are antiviral medications that are used to treat the symptoms until the virus runs its course. The fact that most people are not tested for the H1N1 virus is concerning.
The numbers of people who actually carry this virus has to be unknown if everyone infected with flu symptoms has not been tested. Even though most people with this virus have a mild form of it, I would think that The World Health Organization and the Centers for Disease Control and Prevention would want to know how many cases are out there whether the infected people have severe symptoms or not. If this virus is more widespread than we think, perhaps it’s possible for an even larger strain to develop that we are not prepared for. I’m wondering why it is recommended to be vaccinated this year to prevent this illness if there is not enough concern for doctors to even test for it. The fatality rate is the same for the H1N1 virus as it is for the common flu and most of us have functioned just fine without a vaccination for that.
The H1N1 vaccination is not a cure for the virus as it is simply a preventative measure. Flu vaccines are on average 70-80% effective according to information provided by Fox News. Keep in mind that if you take this vaccine, you will be injected with a form of the virus that has been grown inside chicken eggs in a laboratory. Testing for the product’s safety just began earlier this month and it is already deemed to be safe. It is now being “tested” on pregnant women and children. Are these pregnant women and parents of these children who are being “tested” willing participants? It is possible for a person to develop immunity about 5 weeks after the vaccination process is complete, allowing you to fall victim to the virus in the meantime.
This is due to the fact that each person will need at least two rounds of the vaccine for it to be effective. It is said that there will only be a portion of the vaccines available in October, then more vaccinations will be released each month thereafter. Is this a way to test the vaccine that was just recently reconstructed from the same type of vaccine that was administered in 1976? This is not all that concerns me. They will also be throwing in additives that have never been tested to the second batch of vaccines. How long will they test that batch if it hasn’t even been created yet?
Do I want to vaccinate my daughter? I think not, and I hope it does not become mandatory. I have weighed the pros and cons of getting her vaccinated. Do I take extra precautions so my daughter does not get the virus that is practically identical to the common flu? Keeping her safe from the flu doesn’t seem as important as preventing the problems that can occur from taking the vaccine. The vaccine administered in 1976 and the cases of Guillain-Barré syndrome that resulted from it is concerning. I would rather my child have a mild form of the flu than to die from her immune system attacking her nervous system later in life. Neurologists have already been alerted to keep their eyes open for new cases of Guillain-Barré syndrome when the vaccination is released. It seems that the risks outweigh the benefits with this vaccine, but it’s not easy for drug companies to turn down an opportunity to make a killing in revenue.

The H1N1 virus, better known as the swine flu, is projected to be a major threat this winter. We hear about this virus in the news and are aware of its existence, but most of us are not aware of its history or the effectiveness of the vaccines that were created to treat this strain of influenza. I chose to research information about the H1N1 virus to make a more educated decision on whether or not I should have my daughter vaccinated.

The presence of this virus was brought to our attention in the spring of 2009 when the Mexican government began closing most of the public facilities in Mexico City due to an outbreak. Evidently, there was already a case of widespread swine flu there before it caught our attention. It spread to the United States as well as many other countries by June of 2009. The swine flu dates back to 1918 when it was commonly referred to as the Spanish Flu, though its origin was never detected. Five hundred million people were affected world-wide and 50 to 100 million people died as result. The virus attacked people with healthy immune systems and the popular idea that children and elderly people would be affected the most was not the case. A healthy immune system would over-do itself to try to beat the virus and in the meantime, it would overreact and actually have the reverse effect on the body.

A strain of H1N1 was responsible for a smaller outbreak in 1976 where a soldier at Fort Dix died right after complaining of not feeling well. This strain was controlled, but a new one was born right after which spread very quickly. A vaccination was created to prevent the re-occurrence of the epidemic that took so many lives in 1918. The vaccination helped with the spread of the virus, but it ended up taking more lives than the virus itself. Many died as the result of adverse reactions to the vaccine and 532 people were diagnosed with Guillian-Barré syndrome as a direct result from taking it. This is an autoimmune disorder that results in nerve damage among many other debilitating health problems. Many people who have Guillian-Barré syndrome need to undergo a form of dialysis where antibodies are removed from the blood and the blood is replenished back to the body. It is possible to survive this health condition but there is usually a long road to recovery which can take many years.

There was a limited case of swine flu labeled as Zoonosis which was detected in 1988 when a pregnant woman in Wisconsin died after being in contact with infected pigs at a fair. There were a few others who came in contact with her that were infected with a mild form of the virus. Many pigs were found to be infected across the entire U.S. in 1998 and it was deemed that the pigs had a typical flu that transformed into a new strain due to a combination of their own flu fused with those of humans and birds. Many pigs were infected in the Philippines in 2007 as well. The H1N1 virus is a combination of influenza spun from four different forms including 2 parts human flu, 1 part bird flu and 1 part pig flu.

The 2009 H1N1 virus exhibits symptoms that are similar to your everyday flu. These include a sudden fever and cough along with any of the other common flu symptoms like chills and body aches. Most people who catch the virus can treat it as they normally would with bed rest and fluids. People who have a weakened immune system can experience further complications like pneumonia or even respiratory failure. Those who are considered to be at a higher risk are people under 5 and over 65 years old. People who have recently undergone asthma treatments by taking prescription drugs are also at risk. H1N1 can have an incubation period of up to 7 days, though this has not been confirmed. It can be acquired the same way as the common flu through something as simple as a sneeze. One out of 1,000 people died of the swine flu which is comparable to the amount of people who have died from common flu. The best way to prevent from getting sick is by routine hand washing and covering your mouth and nose with a tissue when you sneeze or cough and quickly disposing it.

How do we know if we have a common flu or the swine flu? In most cases we don’t and physicians normally do not test patients to differentiate which virus they have. They will conduct a test if the symptoms are severe by administering a blood test or swabbing the back of the nose and throat. H1N1 is usually treated with Tamiflu or Relenza when it is diagnosed. These are antiviral medications that are used to treat the symptoms until the virus runs its course. The fact that most people are not tested for the H1N1 virus is concerning.

The numbers of people who actually carry this virus has to be unknown if everyone infected with flu symptoms has not been tested. Even though most people with this virus have a mild form of it, I would think that The World Health Organization and the Centers for Disease Control and Prevention would want to know how many cases are out there whether the infected people have severe symptoms or not. If this virus is more widespread than we think, perhaps it’s possible for an even larger strain to develop that we are not prepared for. I’m wondering why it is recommended to be vaccinated this year to prevent this illness if there is not enough concern for doctors to even test for it. The fatality rate is the same for the H1N1 virus as it is for the common flu and most of us have functioned just fine without a vaccination for that.

The H1N1 vaccination is not a cure for the virus as it is simply a preventative measure. Flu vaccines are on average 70-80% effective according to information provided by Fox News. Keep in mind that if you take this vaccine, you will be injected with a form of the virus that has been grown inside chicken eggs in a laboratory. Testing for the product’s safety just began earlier this month and it is already deemed to be safe. It is now being “tested” on pregnant women and children. Are these pregnant women and parents of these children who are being “tested” willing participants? It is possible for a person to develop immunity about 5 weeks after the vaccination process is complete, allowing you to fall victim to the virus in the meantime.

This is due to the fact that each person will need at least two rounds of the vaccine for it to be effective. It is said that there will only be a portion of the vaccines available in October, then more vaccinations will be released each month thereafter. Is this a way to test the vaccine that was just recently reconstructed from the same type of vaccine that was administered in 1976? This is not all that concerns me. They will also be throwing in additives that have never been tested to the second batch of vaccines. How long will they test that batch if it hasn’t even been created yet?

Do I want to vaccinate my daughter? I think not, and I hope it does not become mandatory. I have weighed the pros and cons of getting her vaccinated. Do I take extra precautions so my daughter does not get the virus that is practically identical to the common flu? Keeping her safe from the flu doesn’t seem as important as preventing the problems that can occur from taking the vaccine. The vaccine administered in 1976 and the cases of Guillain-Barré syndrome that resulted from it is concerning. I would rather my child have a mild form of the flu than to die from her immune system attacking her nervous system later in life. Neurologists have already been alerted to keep their eyes open for new cases of Guillain-Barré syndrome when the vaccination is released. It seems that the risks outweigh the benefits with this vaccine, but it’s not easy for drug companies to turn down an opportunity to make a killing in revenue.

Opportunity Analysis of H1N1 (swine flu) Vaccination Market

H1N1 Influenza A (2009) is the first pandemic influenza of 21st century affecting more than four lac people in more than 180 countries across the globe in 2009. The flu broke in Mexico in the month of March and then affected U.S. and after that it spread across the globe. H1N1 (2009) influenza have a mutation of pig, bird and humans which has made it more dangerous and fatal compared to previous occurrence of H1N1 (1918). ( http://www.bharatbook.com/Market-Research-Reports/Opportunity-Analysis-of-H1N1-swine-fluVaccination-Market.html )

The pandemic outbreak of the influenza opened the gates for the drugs such as Tamiflu in the initial phase for the curing of the disease but the following phase will see a shift from curing to prevention. Thus, arise the requirement for the vaccine for the treatment of H1N1. H1N1 vaccine market is the forecast for the upcoming vaccines for the prevention of the disease among the unaffected population. The vaccines market is classified for the intramuscular vaccines and intranasal vaccines. Intramuscular will cater 80-85% of market revenues and the remaining will be tapped by the intranasal vaccines. The initial lot of vaccines will be of egg based and cell based manufacturing. The market forecast is from late 2009 as the first lot of doses are expected to be rolled out in the first week of October 2009.

The first movers of the in the vaccines market are Glaxo Smith Kline (GSK), Novartis, CSL, Medimmune, Baxter, Sinovec and Sanofi Pastuer. Medimmune is the only producer of the intranasal vaccine whereas other companies are expected to come out with intramuscular vaccines. The companies have got approvals for their first lots from the governments of the various countries such as U.S., U.K., France, China, Denmark and Australia. The involvement of government bodies, increased awareness about prevention and pandemic situation of the influenza is driving the market for the vaccines. Due to intensive ongoing research and technology introduction, the market players are compelled to understand the market dynamics, innovations, pricing, products, marketing and regulatory framework of the market.

The global H1N1 Influenza vaccine market is estimated to be of 676 million in 2009 with first lot of doses being commercialized on 30th September’ 2009. The market will see a high CAGR for the next two years i.e. the market is expected to be at $7.03 billion in 2011 with a CAGR of 222.4% from 2009 to 2011. However, the very high CAGR will settle down by 2012 to 30% for the period of 2009 to 2012. The reason for the sudden settle down of the growth is that it is expected that most of the world population will be immunized by the end of 2011.

Market estimates and forecast

* This report will enable strategic understanding and opportunities in the H1N1 2009 influenza vaccines market. The report covers the following market segments.
* Vaccines Markets: Intramuscular Vaccines and Intranasal vaccines.
* Geography Markets: North America, Europe, Asia-Pacific and ROW

Each section of the report offers market data with respect to segments and geography. It also provides market trends with respect to drivers, restraints and opportunities. The report contains strategic section with respect to competitive landscape and market overview. The report will encompass around 15 company profiles.

To know more and to buy a copy of your report feel free to visit : http://www.bharatbook.com/Market-Research-Reports/Opportunity-Analysis-of-H1N1-swine-fluVaccination-Market.html

Or

Contact us at :

Bharat Book Bureau
Tel: +91 22 27578668
Fax: +91 22 27579131
Email: info@bharatbook.com
Website: www.bharatbook.com
Blog: http://bharatbookresearch.blogspot.com
Follow us on twitter: http://twitter.com/3bbharatbook

REPORT DESCRIPTION

H1N1 Influenza A (2009) is the first pandemic influenza of 21st century affecting more than more than four lac people in more than 180 countries across the globe in 2009. The flu broke in Mexico in the month of March and then affected U.S. and after that it spread across the globe. H1N1 (2009) influenza have a mutation of pig, bird and humans which has made it more dangerous and fatal compared to previous occurrence of H1N1 (1918).

The pandemic outbreak of the influenza opened the gates for the drugs such as Tamiflu in the initial phase for the curing of the disease but the following phase will see a shift from curing to prevention. Thus, arise the requirement for the vaccine for the treatment of H1N1. H1N1 vaccine market is the forecast for the upcoming vaccines for the prevention of the disease among the unaffected population. The vaccines market is classified for the intramuscular vaccines and intranasal vaccines. Intramuscular will cater 80-85% of market revenues and the remaining will be tapped by the intranasal vaccines. The initial lot of vaccines will be of egg based and cell based manufacturing. The market forecast is from late 2009 as the first lot of doses are expected to be rolled out in the first week of October 2009.

The first movers of the in the vaccines market are Glaxo Smith Kline (GSK), Novartis, CSL, Medimmune, Baxter, Sinovec and Sanofi Pastuer. Medimmune is the only producer of the intranasal vaccine whereas other companies are expected to come out with intramuscular vaccines. The companies have got approvals for their first lots from the governments of the various countries such as U.S., U.K., France, China, Denmark and Australia. The involvement of government bodies, increased awareness about prevention and pandemic situation of the influenza is driving the market for the vaccines.

Due to intensive ongoing research and technology introduction, the market players are compelled to understand the market dynamics, innovations, pricing, products, marketing and regulatory framework of the market.

The global H1N1 Influenza vaccine market is estimated to be of 676 million in 2009 with first lot of doses being commercialized on 30th September’ 2009. The market will see a high CAGR for the next two years i.e. the market is expected to be at $7.03 billion in 2011 with a CAGR of 222.4% from 2009 to 2011. However, the very high CAGR will settle down by 2012 to 30% for the period of 2009 to 2012. The reason for the sudden settle down of the growth is that it is expected that most of the world population will be immunized by the end of 2011.

Market estimates and forecast

This report will enable strategic understanding and opportunities in the H1N1 2009 influenza vaccines market. The report covers the following market segments.

Vaccines Markets: Intramuscular Vaccines and Intranasal vaccines.

Geography Markets: North America, Europe, Asia-Pacific and ROW

Each section of the report offers market data with respect to segments and geography. It also provides market trends with respect to drivers, restraints and opportunities. The report contains strategic section with respect to competitive landscape and market overview. The report will encompass around 15 company profiles

What makes our reports unique?

- We provide the longest market segmentation chain in this industry- not many reports provide market breakdown upto level 5.
- We provide 10% customization. Normally it is seen that clients do not find specific market intelligence that they are looking for. Our customization will ensure that you necessarily get the market intelligence you are looking for and we get a loyal customer.
- We conduct detailed market positioning, product positioning and competitive positioning. Entry strategies, gaps and opportunities are identified for all the stakeholders.
- Comprehensive market analysis for the following sectors:
Pharmaceuticals, Medical Devices, Biotechnology, Semiconductor and Electronics, Energy and Power Supplies, Food and Beverages, Chemicals, Advanced Materials, Industrial Automation, and Telecom and IT. We also analyze retailers and super-retailers, technology providers, and research and development (R&D) companies.

Key questions answered

- Which are the high-growth segments/cash cows and how is the market segmented in terms of applications, products, services, ingredients, technologies, and stakeholders?
- What are market estimates and forecasts; which markets are doing well and which are not?
- Where are the gaps and opportunities; what is driving the market?
- Which are the key playing fields? Which are the winning edge imperatives?
- How is the competitive outlook; who are the main players in each of the segments; what are the key selling products; what are their strategic directives, operational strengths and product pipelines? Who is doing what?

Powerful Research and analysis

The analysts working come from renowned publishers and market research firms, globally, adding their expertise and domain understanding. We get the facts from over 22,000 news and information sources, a huge database of key industry participants and draw on our relationships with more than 900 market research companies across the world. We are inspired to help our clients grow by providing qualitative business insights with our huge market intelligence repository.

For more information, please visit :

http://www.aarkstore.com/reports/Opportunity-Analysis-of-H1N1-swine-flu-Vaccination-Market-32318.html

Or email us at press@aarkstore.com or call +919272852585